Regulatory tracker
Daily aggregated filings from FDA, DEA, SEC, CMS, and the Federal Register, filtered for mental health relevance.
CT An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy, INTUITIVE EATING, Perceived Stress, Prenatal Depression, Anxiety, Diet Quality, Physical Activity, Body Awareness — Intuitive Eating Intervention
View on ClinicalTrials.gov CT REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness
Major Depressive Disorder (MDD) — Rejoyn, Cognitive Behavioral Therapy (CBT) exercises
View on ClinicalTrials.gov CT Oral Thiamine (Vitamin B1) for Depression in Children and Adolescents
Major Depressive Disorder (MDD), Thiamine, Vitamin B1, Thiamine Diphosphate (TDP), Pediatrics — thiamine hydrochloride 100 mg
View on ClinicalTrials.gov CT Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV
PrEP Use — PrEPared Minds/ Mentes PrEParadas - Cognitive Behavioral Therapy, No Intervention
View on ClinicalTrials.gov CT Simulation-Based Subcutaneous Injection Training in Midwifery Students
Simulation Training, Midwifery Education, Subcutaneous Injection — Mannequin-Based Subcutaneous Injection Training, Peer-Based Subcutaneous Injection Training, Self-Based Subcutaneous Injection Training
View on ClinicalTrials.gov CT Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Post-Traumatic Stress Disorder, PTSD — Propranolol, Psychotherapy
View on ClinicalTrials.gov CT Psilocybin-Assisted Psychotherapy for Veterans With PTSD
Posttraumatic Stress Disorder (PTSD) — Psilocybin-assisted Psychotherapy
View on ClinicalTrials.gov CT Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
Opioid Abuse (Disorder), Clinical Decision Support — Refined EMBED CDS, Provider alert that nurse completed COWS
View on ClinicalTrials.gov DEA Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration
View on Federal Register DEA Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4- chlorobenzyl)piperidin-
View on Federal Register CT The Effects of a Caregiver-initiated Reading Intervention to Their Infant in the Neonatal Intensive Care Unit
Infant Admitted to Neonatal Intensive Care Unit (NICU) — Reading Intervention
View on ClinicalTrials.gov CT Progressive Muscle Relaxation and Kinesio Taping for Premenstrual Syndrome
Premenstrual Syndrome — Progressive Muscle Relaxation Exercise, Kinesio Taping
View on ClinicalTrials.gov CT Developing and Testing the Efficacy of AI-Chatbot-Based
Breast Cancer — AIAI-Chatbot CalmMindRecoveryJourney delivering BMS-MC therapy
View on ClinicalTrials.gov CT Using a School-Based Depression Literacy Psychoeducation Program With AI Chatbot to Improve Depression Literacy and Help-Seeking Among High School Students
Depressive Symptoms, Mental Health (Depression) — school-based depression literacy program
View on ClinicalTrials.gov CT Activating Voice Journaling for Mental Health With Voice Biomarkers
Depression / Major Depressive Disorder, Anxiety
View on ClinicalTrials.gov CT Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety — Partners in Parenting, Shamiri
View on ClinicalTrials.gov CT Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality
Hypertension, Poor Sleep Quality, Insomnia, Arterial Stiffness — Behavioral: Cognitive-Behavioural Therapy for Insomnia (CBT-I), Passive sleep education
View on ClinicalTrials.gov CT Effect of Utilizing Virtual Reality With Pulmonary Rehabilitation on Depression in COPD Patients
COPD Patients, Depression in Chronic Obstructive Pulmonary Disease — virtual reality with pulmonary rehabilitation, controlled group received pulmonary rehabilitation without utilizing virtual reality
View on ClinicalTrials.gov CT THE EFFECT OF MINDFULNESS IN INFLAMMATION MARKERS (IL-6, TNF-Α, CRP AND CORTISOL) AMONG SURVIVORS OF TIDAL FLOODING IN SAYUNG DEMAK
Psychological Stress, Depression - Major Depressive Disorder, Anxiety, Inflammation, Disaster — Mindfulness Body Scan Training
View on ClinicalTrials.gov CT Enhanced Recovery Protocol Compliance and Quality of Recovery After Cesarean Delivery
Cesarean Section, Postoperative Recovery, Postoperative Pain — Assessment of Enhanced Recovery Protocol Compliance
View on ClinicalTrials.gov CT Passiflora Incarnata for Dental Extraction Anxiety
Dental Anxiety, Preoperative Anxiety — Passiflora incarnata extract, Placebo
View on ClinicalTrials.gov CT Mandala Coloring and Music for Cancer Fear and Screening Anxiety
Cancer Fear and Screening-Related Anxiety in Women Undergoing Cancer Screening — mandala, Music
View on ClinicalTrials.gov CT Predictors of Severe Postoperative Pain Within 24 Hours After Elective Cesarean Delivery Under Spinal Anesthesia
Cesarean Section, Postoperative Pain After Cesarean Section, Acute Pain — Observational Assessment of Postoperative Pain
View on ClinicalTrials.gov CT Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit Smoking
Nicotine Dependance, Serious Mental Illness, Smoking (Tobacco) Addiction, Tobacco Cessation, Community Health Workers, Cardiovascular (CV) Risk, Tobacco Use Disorder — Integrated CHW Support intervention, Enhanced usual care (EUC)
View on ClinicalTrials.gov CT Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking Cessation
Smoking Cessation, Cigarette Smoking, Tobacco Use, Nicotine Dependence — Mindful Smoking and Sensor-Band Intervention, Smoking Cessation Information
View on ClinicalTrials.gov CT Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
Neuropsychiatric Symptom
View on ClinicalTrials.gov CT Unipolar Versus Bipolar Radiofrequency Ablation in Knee Osteoarthritis Pain
Bipolar Radiofrequency Ablation, Unipolar Radiofrequency Ablation, Knee Osteoarthritis, Pain — Unipolar radiofrequency ablation, Bipolar radiofrequency ablation
View on ClinicalTrials.gov DEA Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever
View on Federal Register DEA Importer of Controlled Substances Application: Curia New York Inc.
Curia New York Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Experic LLC
Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Cambrex Charles City
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register FDA International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight drug subst
View on Federal Register CT Mandala Coloring and Resilience in Midwives
Psychological Resilience Among Midwives Working in Delivery Rooms — Mandala Coloring
View on ClinicalTrials.gov CT Family-authored Digital ICU Diary Intervention to Support Bereaved Family Members in Intensive Care Unit: A Pilot Mixed Methods Study
Bereavement — Family-authored Digital ICU Diary Intervention, Standard Care
View on ClinicalTrials.gov CT The Goal is to Examine the Impact of Doula-coordinated, Midwife-delivered Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
Doula Support, Postpartum, Postpartum Anaemia, Postpartum Depression (PPD) — Doula-coordinated, Midwife-delivered postpartum care
View on ClinicalTrials.gov CT The Effect of Ostomy Care Education Applied With the Teach-Back Method to Ostomy-Opened Individuals on Self-Care Power, Ostomy Adjustment, and Anxiety
Ostomy - Ileostomy or Colostomy, Canser, Ileus, Intestinal Cancer — TEACH BACK METHOD
View on ClinicalTrials.gov CT Antenatal Bre-Lax Education for Perinatal Anxiety Reduction and Self-efficacy Among Pregnant Women in Karachi's Urban Slums
Perinatal Anxiety — Arm 2: BreLax Intervention Group 1, Arm 3: Combined Intervention Group 3
View on ClinicalTrials.gov CT A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder — SEP-363856
View on ClinicalTrials.gov CT Ukulele Music on Pain, Anxiety, and Postpartum Comfort
Postpartum — Live Ukulele Music
View on ClinicalTrials.gov CT The Effect of Simulation-Based Oxytocin Induction Training on Midwifery Students' Knowledge and Anxiety Levels
Simulation-based Midwifery Education, Oxytocin Induction — Theoretical Training on Oxytocin Induction, Simulation-Based Oxytocin Induction Training
View on ClinicalTrials.gov CT téléwork and Consumer Behavior: Longitudinal Study
Addictions — data collection
View on ClinicalTrials.gov CT Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase
Opioid Use Disorder — STORC
View on ClinicalTrials.gov CT Sensory and Physical Reactions to Beverage Cues
Alcohol Use Disorder (AUD) — Alcohol Cue Reactivity Paradigm
View on ClinicalTrials.gov CT NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment — Perceptual Discrimination Training, Cognitive Control Training
View on ClinicalTrials.gov CT Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Psychotic Disorders, Prodromal Symptoms — Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS
View on ClinicalTrials.gov DEA Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Chattem Chemicals
Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.
Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory
Scottsdale Research Institute SRI Montana Satellite Laboratory has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc.
Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Vici Health Sciences, LLC
Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Importer of Controlled Substances Application: Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Curia New York Inc
Curia New York Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register DEA Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
View on Federal Register CT Early Detection of Perinatal Depression With Wearable Technology
Perinatal Depression — Oura Ring (Photoplethysmography-based wearable ring), EmbracePlus Watch (Electrodermal activity wristband sensor)
View on ClinicalTrials.gov CT Precision Closed-loop Brain-Computer Interface Neuromodulation for Treatment-Resistant Depression
Treatment-Resistant Major Depressive Disorder, Major Depressive Disorder — Closed-loop Deep Brain Stimulation (DBS), Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
View on ClinicalTrials.gov CT A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
Outpatients or Inpatients With Depression — Shugan Jieyu Capsules
View on ClinicalTrials.gov CT Identifying Biomarkers of Response to Digital Interventions for Mood Disorders
Depression / Major Depressive Disorder, Bipolar Disorder (BD) — Online Cognitive Behavioural Therapy
View on ClinicalTrials.gov CT Individualized (fMRI-guided) TMS Intervention for PTSD
PTSD, Post Traumatic Stress Disorder (PTSD) — Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)
View on ClinicalTrials.gov CT Adjunctive Probiotic Therapy in Major Depressive Disorder: A Randomized Controlled Trial (ProMOOD)
Depression / Major Depressive Disorder — OMNi-BiOTiC® STRESS Repair, Matched Placebo Powder for Oral Solution
View on ClinicalTrials.gov CT Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
Major Depression — TMS, NRX-101
View on ClinicalTrials.gov CT Effects of Online Laughter Yoga and Psychoeducation on Perceived Stress and Career Anxiety in Nursing Students
The Effect of Online Laughter Yoga Combined With Psychoeducation on Perceived Stress and Career Anxiety Among Nursing Students — Laughter Yoga Programme, Psychoeducational Programme
View on ClinicalTrials.gov CT Yintang Acupressure During Labor in Primiparous Women
Labor Pain, Anxiety — Yintang Acupressure, Sham Light Touch
View on ClinicalTrials.gov CT The Effect of Mandala Coloring, Sleep Quality, Anxiety With Premenstrual Syndrome
Premenstrual Syndrome — Mandala coloring group
View on ClinicalTrials.gov CT Varenicline as a Treatment for Cannabis Use Disorder
Cannabis Abuse — Varenicline (Chantix), Placebo
View on ClinicalTrials.gov CT Chemokine Receptors on CD8+ T Cells in Patients With Bipolar Disorder
Bipolar Affective Disorders — CD8+ T-Cell Gene Expression Analysis
View on ClinicalTrials.gov CT Supported Online Self-Help for Veterans With Depression in Primary Care
Depression — Enhanced Usual Care (EUC), Supported Online Self-help for Depression (SOS-Depression)
View on ClinicalTrials.gov CT Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy
Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features — Lurasidone, Placebo, Background Antidepressant Therapy
View on ClinicalTrials.gov CT Action Observation and Motor Imagery Training in Cervical Disc Herniation
Cervical Disc Herniation, Chronic Pain, Kinesiophobia, Cervical Pain — Conventional Physiotherapy, Action Observation and Motor Imagery Training, Sham Observation
View on ClinicalTrials.gov CT 40-Hz Audiovisual Stimulation in Schizophrenia Spectrum Disorders
Anxiety — 40-Hz Binaural Beat Music Combined With 40-Hz Rhythmic Photic Stimulation, Sham group
View on ClinicalTrials.gov CT Immersive Virtual Reality for Pain and Dental Anxiety During Pediatric Restorative Treatment
Dental Anxiety in Children, Dental Pain, Virtual Reality, Distraction, Dental Caries — Immersive Virtual Reality
View on ClinicalTrials.gov CT The Effect of Diaphragmatic Breathing Exercises Before Gastroscopy on Anxiety, Fear, and Vital Signs
Breath Exercise, State Anxiety, Adult Patients, Vital Signs Monitoring, Fear — Diaphragmatic Breathing Exercises
View on ClinicalTrials.gov CT Effectiveness of A Multi-Component Self-Management Intervention for Anxiety and Respiratory-Related Symptoms in Patients With Lung Cancer
Cancer — M-RDSI, RDSI, Usual Care
View on ClinicalTrials.gov CT Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial
Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Written Exposure Therapy, Treatment as Usual
View on ClinicalTrials.gov CT Grappling With Trauma: Brazilian Jiu-Jitsu for First Responders
Post-traumatic Stress Disorder (PTSD), Trauma and Stress Related Disorders, Occupational Stress, Emotional Regulation Difficulties, Anger Problems, Relational Problems, Irritability — Brazilian Jiu-Jitsu Program
View on ClinicalTrials.gov CT Improving Quality of Informal Care for People With Schizophrenia
Schizophrenia — Dyadic Multicomponent Intervention (DMI), Dyadic Benefit-Finding Intervention (DBFI)
View on ClinicalTrials.gov CT Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
Schizophrenia — xanomeline-trospium chloride, Oral antipsychotics
View on ClinicalTrials.gov CT Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
Schizophrenia — Scaffolding-Based Board Game Intervention
View on ClinicalTrials.gov CT Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
Behavioral Intervention, Nicotine Addiction — Standard phone call, phone call with MINDSPACE elements
View on ClinicalTrials.gov CT Personalized Addiction Treatment enHancement
Opioid Use Disorder, mHealth, Peer Support — Vira Platform, Treatment-As-Usual
View on ClinicalTrials.gov CT Tension-type Headache and Its Association
Tension-Type Headache, Sleep Disturbance, Smartphone Addiction, Quality of Life
View on ClinicalTrials.gov CT TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe — TRTME
View on ClinicalTrials.gov CT How Does the Opioid System Shape Stress and Social Behaviour in Men and Women and What Role Does Childhood Unpredictability Play?
Stress, Early Life Stress, Sex Differences, Opioid — Morphine, Placebo
View on ClinicalTrials.gov CT Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment
Depression Disorder — Individualized resting-state functional connectivity-guided iTBS, Symptom-titrated algorithm-based longitudinal ECT (STABLE) algorithm
View on ClinicalTrials.gov CT DecNef for AVH in Schizophrenia
Schizophrenia Disorder, Schizoaffecitve Disorder — Decoded Neurofeedback
View on ClinicalTrials.gov CT IPV Prevention Among FDP
PTSD Symptoms, Violence Prevention, Depression and Anxiety Symptoms — EA$E-US, ongoing standard of care
View on ClinicalTrials.gov CT EMDR Grief Protocol for Traumatic Grief After Earthquake-Related Loss
Traumatic Grief, Post Traumatic Stress Disorder PTSD, Emotional Processing — EMDR Grief Protocol
View on ClinicalTrials.gov CT ONE-P TMS Military Veterans
PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)
View on ClinicalTrials.gov CT Virtual Reality (VR)and Mobile-Based Smoking Cessation in Breastfeeding Mothers
Smoking Cessation, Tobacco Use Disorder, Breast Feeding — Virtual Reality and Mobile Application-Based Smoking Cessation Education
View on ClinicalTrials.gov CT Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Pregnancy, Substance Use Disorder (SUD) — Contingency Management, Social Drivers of Health Screening
View on ClinicalTrials.gov CT Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder
Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving — Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO
View on ClinicalTrials.gov CT Group DBT Skills Training for First Episode Psychosis
Psychosis — group DBT
View on ClinicalTrials.gov CT ONE-P TMS First Responders
PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)
View on ClinicalTrials.gov CT Evaluation of a Modularized Cognitive Behavioral Group Therapy Programme for Young Adults (CHANGE-Study)
Psychiatric Disorder — CHANGE - modularized group psychotherapy
View on ClinicalTrials.gov CT Short-Term Psychodynamic Group Therapy for Problematic Pornography Use
Addiction — Short-Term Psychodynamic Group Therapy
View on ClinicalTrials.gov CT Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Alcohol Use Disorder (AUD), Obesity (BMI Equal to or >30) — Placebo, Semaglutide 1.0 mg, Semaglutide 2.0 mg
View on ClinicalTrials.gov CT Psilocybin for Methamphetamine Use Disorder
Methamphetamine Use Disorder — Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific doses withheld during conduct)., Manualized cognitive behavioral therapy platform (2 preparation + 2 integration sessions).
View on ClinicalTrials.gov CT Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)
Schizophrenia — Active rTMS, Strong Cognitive Training, Sham rTMS
View on ClinicalTrials.gov CT Efficacy and Safety of Temporal Interference Stimulation in Treatment-Resistant Schizophrenia: An Exploratory Study.
Treatment-resistant Schizophrenia — Temporal Interference Stimulation
View on ClinicalTrials.gov CT The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD
PTSD, Posttraumatic Stress Disorder — methylphenidate (Ritalin®), Reboxetine, Placebo
View on ClinicalTrials.gov CT Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior
HIV, Risk Behavior, Alcohol Abuse — CLT- Concrete text messages, CLT- Abstract text messages, Control messages
View on ClinicalTrials.gov CT Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder
Opioid Use Disorder, Tobacco Use Disorder — Deep TMS System With H4 Coil
View on ClinicalTrials.gov CT Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance — Semaglutide + TAU, Placebo + TAU
View on ClinicalTrials.gov CT Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
SCHIZOPHRENIA 1 (Disorder) — physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group
View on ClinicalTrials.gov CT Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Major Depressive Disorder (MDD)
View on ClinicalTrials.gov CT EEG and Actigraphy Biomarkers of Written Exposure Therapy for Posttraumatic Stress Disorder
Posttraumatic Stress Disorder (PTSD) — Written Exposure Therapy, Neutral Writing Condition
View on ClinicalTrials.gov CT Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s) — Unconscious Trauma Reactivation plus Eye Movements, Active Trauma Memory Reactivation plus Eye Movements, Neutral Memory Reactivation plus Eye Movements
View on ClinicalTrials.gov CT Real-time Opioid Study
Substance Use Disorder (SUD) — real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback
View on ClinicalTrials.gov CT Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Schizophrenia, Antipsychotic Drug — Xingqi Daozhi Decoction, Placebo Group
View on ClinicalTrials.gov CT Project MOVE Bipolar
Bipolar Disorder (BD) — BA, SHE, HE
View on ClinicalTrials.gov DEA Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through Jun
View on Federal Register CT NEST: A Group Intervention for Parents With Complex PTSD
Complex Post-Traumatic Stress Disorder — Trauma-Informed Parenting Group Intervention
View on ClinicalTrials.gov CT MDMA-AT for PTSD in Young Adults With Childhood Trauma
Posttraumatic Stress Disorder (PTSD) — MDMA assisted psychotherapy
View on ClinicalTrials.gov DEA Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and e
View on Federal Register CT Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)
Written Exposure Therapy — Written Exposure Therapy (WET)
View on ClinicalTrials.gov CT Study of rTMS in Maintenance in Treatment Resistant Depression
Treatment Resistant Depression (TRD) — Transcranial Magnetic Stimulation, quetiapine
View on ClinicalTrials.gov CT A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
SCHIZOPHRENIA 1 (Disorder) — HS-10380
View on ClinicalTrials.gov CT Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms — Deferiprone (DFP), N-Acetyl Cysteine (NAC)
View on ClinicalTrials.gov DEA Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyri
View on Federal Register CT The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic Stress and Substance Use Disorder Symptoms
Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Trauma Informed Heart Rate Variability Biofeedback, Present Centered Therapy
View on ClinicalTrials.gov CT Intergenerational Risk and Resilience of Rohingya in Displacement
Child Development, Early Child Development, Mental Health, PTSD - Post Traumatic Stress Disorder, Intergenerational Trauma, Refugee Health
View on ClinicalTrials.gov CT Impact of De Quervain's Tenosynovitis on Grip Strength and Quality of Life in Smartphone-Addicted Adolescents
Hand Grip Strength, Quality of Life
View on ClinicalTrials.gov CT Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) — Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support
View on ClinicalTrials.gov CT One-Day cTBS Over the Precuneus
Depressive Disorder, Treatment-Resistant, Treatment Resistant Depression (TRD), Treatment Resistant Major Depression Disorder — Precuneus-targeted continuous theta-burst stimulation, Left dorsolateral prefrontal cortex intermittent theta-burst stimulation, Sham transcranial magne
View on ClinicalTrials.gov CT Simulation-Based Schizophrenia Training in Nursing Education
SCHIZOPHRENIA 1 (Disorder), Simulation Based Learning, Nursing Students — Simulation
View on ClinicalTrials.gov CT Aerobic, Resistance and Inspiratory Muscle Training in Adults With Severe Mental Disorder
Severe Mental Disorder — Supervised multicomponent exercise programme
View on ClinicalTrials.gov CT Effects of Very Low Nicotine Content Cigarettes Among Adults Who Smoke Daily in South Korea
Cigarette Smoking, Nicotine Dependence — SPECTRUM cigarettes, SPECTRUM cigarettes
View on ClinicalTrials.gov CT Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder
Alcohol Use Disorder (AUD), Alcoholism — Repetitive transcranial magnetic stimulation
View on ClinicalTrials.gov CT Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
Schizophrenia, Schizoaffecitve Disorder — Digital therapeutic (AffectUs), Psychoeducational materials
View on ClinicalTrials.gov CT Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation, Psychosis, Suicidal Behavior — Suicide Prevention Intervention, Standard Care (in control arm)
View on ClinicalTrials.gov CT Effectiveness of Acceptance and Commitment Therapy in Promoting Mental Health of Emerging Adults With Internet Addiction
Internet Addiction — Acceptance and Commitment Therapy (ACT)
View on ClinicalTrials.gov CT Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity
Opioid Abuse (Disorder), Opioid Analgesia, Opioid Analgesic Adverse Reaction, Opioid Consumption — Naproxen, Acetaminophen, oxycodone
View on ClinicalTrials.gov CT Comparison Between Traditional Bipolar Radiofrequency and Cooled Radiofrequency in Sacroiliac Joint Pain Patients
Sacroiliac Joint Pain — Traditional bipolar radiofrequency, Cooled radiofrequency
View on ClinicalTrials.gov CT Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleation
Prostatic Hyperplasia, Lower Urinary Tract Symptoms — Hydrodissection-Assisted Bipolar Prostatic Enucleation-Enucleoresection, Conventional Bipolar Prostatic Enucleation-Enucleoresection
View on ClinicalTrials.gov CT Examining Lithium's Mechanism in Bipolar Disorder
Healthy, Bipolar — Lithium carbonate (Priadel), Controlled light exposure
View on ClinicalTrials.gov CT Enhancing Resilience and Quality of Life in Bipolar Disorder Through Cognitive Behavioral Therapy
Bipolar Affective Disorder; Remission in — CBT-Based Psychological Resilience Enhancement Program for Individuals with BD
View on ClinicalTrials.gov CT PTSD Risk Prediction Model for EICU Survivors
Post-traumatic Stress Disorder (PTSD)
View on ClinicalTrials.gov CT Recovery Opportunities Through Ongoing Treatment Sustainment
Substance Use Disorders (SUDs) — Youth Substance Use Unit
View on ClinicalTrials.gov CT EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT
Major Depression Moderate, Major Depression Severe, Major Depression With Comorbid Anxiety Symptoms, Major Depression With Panic Attacks, Major Depression With Psychotic Features, Major Depressive Episode, Major Depressive Disorder (MDD, Major Depression — Electroconvulsive Thera
View on ClinicalTrials.gov CT The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis
Cognitive Functioning, Psychosis — Active tDCS, Sham tDCS, Yoga
View on ClinicalTrials.gov CT Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia
SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder, Alcohol Dependence (Primary Condition) — Snoezelen® therapy for 6 weeks, Snoezelen® therapy for 12 weeks
View on ClinicalTrials.gov CT Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PTSD, PTSD - Post Traumatic Stress Disorder, Major Depression, Suicidality — Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback
View on ClinicalTrials.gov CT Supportive Treatment With Enhanced Post-Incarceration Services
Substance Use Disorders (SUDs) — Individually Tailored Behavioral Activation, Formerly Incarcerated Transitions Program
View on ClinicalTrials.gov CT Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention
Prevention, Risk Factors for Mental Illness, Family History of Schizophrenia Spectrum Disorder — Psychosocial intervention group
View on ClinicalTrials.gov CT An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)
Bipolar 1 Disorder, Schizophrenia Disorder — OLZ/SAM
View on ClinicalTrials.gov CT The Effect of Combined Brain Stimulation and Exercise for Improving Cognitive Function in Schizophrenia
Schizophrenia, Cognitive Functions — Aerobic exercise, Active tDCS, Sham tDCS
View on ClinicalTrials.gov CT Safety and Feasibility of DBS for Bipolar Depression
Bipolar I Disorder, Bipolar Depression — Medtronic Percept PC DBS system
View on ClinicalTrials.gov DEA Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as
View on Federal Register CT Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment
Schizophrenia, Treatment Resistant Depression (TRD), Bipolar Disorder (BD), Catatonia, Obsessive Compulsive Disorder (OCD) — Blood sampling, lumbar puncture, stool sampling, skin microbiopsy and psychometrics scales
View on ClinicalTrials.gov CT Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departments
Intoxication; Opioid — Structured early addiction care, Not structured early addiction care
View on ClinicalTrials.gov CT Tirzepatide Impact Assessment Study
Obesity & Overweight, Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health — GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention
View on ClinicalTrials.gov CT Connecting Loved Ones to Support and Empowering Recovery
Substance Use Disorder (SUD), mHealth — KulaMind-Recovery
View on ClinicalTrials.gov CT EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
Major Depression Moderate, Major Depression Severe, Major Depression With Comorbid Anxiety Symptoms, Major Depression With Panic Attacks, Major Depression With Psychotic Features, Major Depressive Episode, Bipolar Affective Disorder, Bipolar Depression Depressed Phase, Bipolar De
View on ClinicalTrials.gov CT Treatment of Aging Signs of the Skin With Bipolar Radiofrequency
Wrinkles and Rhytides
View on ClinicalTrials.gov CT Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders
Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder — Microcurrent Neurofeedback (MCN), Standard Care for Substance Use Disorder
View on ClinicalTrials.gov CT Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD
Post-Traumatic Stress Disorder, PTSD — Psilocybin (drug), Trauma-Focused Psychotherapy
View on ClinicalTrials.gov CT Acute Effects of Estradiol Administration on Brain Function During Fear Learning
PTSD and Trauma-related Symptoms, Cognitive Decline in Older Adults, Post Menopausal Women — estradiol
View on ClinicalTrials.gov CT A Novel Adaptation of the Unified Protocol (UP) as a Transdiagnostic Intervention for Emotional Disorders in Addictive Behaviors
Addictive Behaviors, Emotion Regulation — Transdiagnostic cognitive-behavioral therapy, Treatment as usual
View on ClinicalTrials.gov CT Repetitive Transcranial Magnetic Stimulation for People With Etomidate Addiction (SToP-E-rTMS x Etomidate)
Etomidate Use Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS) — high-frequency Repetitive Transcranial Magnetic Stimulation, Repetitive transcranial magnetic stimulation
View on ClinicalTrials.gov CT EFFECTIVENESS OF SOLUTION-FOCUSED APPROACH-BASED PSYCHOEDUCATION IN INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER: A RANDOMIZED CONTROLLED TRIAL
Addiction, Theraphy — psychoeducation
View on ClinicalTrials.gov CT Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression
Treatment-resistant Depression (TRD) — Group integration therapy
View on ClinicalTrials.gov CT Self-Compassion, Health, and Empowerment
Intimate Partner Violence (IPV), Depression and/or Anxiety Symptoms, PTSD - Post Traumatic Stress Disorder — The Self-Compassion, Health, and Empowerment (SHE) Intervention, Health and Nutrition Program
View on ClinicalTrials.gov CT Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.
Addiction — Observational assessments (EMA and annual DSM-5 evaluations)
View on ClinicalTrials.gov CT Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models
Bipolar Disorder (BD), Bipolar Disorder (BPD) — Peripheral blood sampling for PBMC isolation
View on ClinicalTrials.gov CT Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes
Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate — TURP, Epinephrine
View on ClinicalTrials.gov CT The Effect of Cognitive Behavioral Psychoeducation on Internalized Stigma in Individuals With Bipolar Disorder
Bipolar Disorder (BD), Internalized Stigma, Psychoeducation — Cognitive-behavioral based psychoeducation program, Standard Care (in control arm)
View on ClinicalTrials.gov